#
# List of treatments for testing.  Each line is the following format:
#
# Gene\tVariant\tTumorType\tTreatments\tLevel
#

# Test KIT
KIT	N505I	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	N505I	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	N505I	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	N505I	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	N505I	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	N505L	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	N505L	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	N505L	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	N505L	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	M541L	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	M541L	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	M541L	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	M541L	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	M541C	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	M541C	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	M541C	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	M541C	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	Y553N	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	Y553N	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	Y553N	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	Y553N	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	Y553C	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	Y553C	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	Y553C	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	Y553C	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	R643W	Gastrointestinal Stromal Tumor
KIT	R643W	Melanoma
KIT	R643W	Colorectal Cancer
KIT	R643W	Thymic Tumor
KIT	D737N	Gastrointestinal Stromal Tumor
KIT	D737N	Melanoma
KIT	D737N	Colorectal Cancer
KIT	D737N	Thymic Tumor
KIT	C809G	Gastrointestinal Stromal Tumor	1: Regorafenib; 2A: Sorafenib; R2: Imatinib; R2: Sunitinib;
KIT	C809G	Melanoma	2A: Imatinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	C809G	Colorectal Cancer	2B: Regorafenib; 2B: Sorafenib;
KIT	C809G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Regorafenib;
KIT	K642E	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	K642E	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	K642E	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	K642E	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	K642G	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	K642G	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	K642G	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	K642G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	V654A	Gastrointestinal Stromal Tumor	1: Sunitinib; 1: Regorafenib; R2: Imatinib;
KIT	V654A	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	V654A	Colorectal Cancer	2B: Sunitinib; 2B: Regorafenib;
KIT	V654A	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Regorafenib;
KIT	V654G	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib;
KIT	V654G	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	V654G	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	V654G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	T670I	Gastrointestinal Stromal Tumor	1: Sunitinib; 1: Regorafenib; R2: Imatinib;
KIT	T670I	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib;
KIT	T670I	Colorectal Cancer	2B: Sunitinib; 2B: Regorafenib;
KIT	T670I	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Regorafenib;
KIT	T670C	Gastrointestinal Stromal Tumor
KIT	T670C	Melanoma
KIT	T670C	Colorectal Cancer
KIT	T670C	Thymic Tumor
KIT	D816A	Gastrointestinal Stromal Tumor	3B: Avapritinib;
KIT	D816A	Melanoma	2A: Imatinib; 3B: Avapritinib;
KIT	D816A	Colorectal Cancer	3B: Avapritinib;
KIT	D816A	Mastocytosis	3A: Avapritinib;
KIT	D816A	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 3B: Avapritinib;
MTOR	L2427Q	Renal Clear Cell Carcinoma	3A: Temsirolimus;
PDGFRA	D842I	GIST	2A: Imatinib;
PDGFRA	D842I	Thymic Tumor	2B: Imatinib;
PDGFRA	D842V	GIST	R1: Imatinib; 2A: Dasatinib;
PDGFRA	D842V	Thymic Tumor	2B: Dasatinib; 2B: Imatinib;
EGFR	A763_Y764insFQEA	NSCLC	1: Afatinib; 1: Erlotinib; 1: Gefitinib; 3A: Poziotinib;
# this one overlaps with A763_Y764insFQEA, but the rule only applies to exact match, so R1 will be used
EGFR	Y764_D770dup	NSCLC	R1: Afatinib; R1: Erlotinib; R1: Gefitinib; 3A: Poziotinib;
# this one does not overlap with A763_Y764insFQEA, so R1 for sure
EGFR	N771delinsSTH	Lung Adenocarcinoma	R1: Afatinib; R1: Erlotinib; R1: Gefitinib; 3A: Poziotinib;

